Jodi Lynne Kusturin, PT, DPT Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 E 3rd St, Russellville, AR 72801 Phone: 479-968-1198 Fax: 479-967-1178 |
Shandy Toland, PT Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine Medicare: Not Enrolled in Medicare Practice Location: 2703 W Main St, Russellville, AR 72801 Phone: 479-890-5494 Fax: 479-968-0069 |
Sara J Whitlock, PT Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine Medicare: Not Enrolled in Medicare Practice Location: 2703 W Main St, Russellville, AR 72801 Phone: 479-890-5494 Fax: 479-968-0069 |
News Archive
BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.
Clinicians may use one of several approaches to deny patient requests for an inappropriate treatment while preserving the physician-patient relationship, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Kaleo, a privately-held pharmaceutical company, today announced a national strategic partnership with the Clinton Health Matters Initiative, an initiative of the Clinton Foundation, that will help support its goal of cutting prescription drug-related deaths in half, saving approximately 10,000 lives over five years.
The Financial Times examines efforts by "Ethiopian policymakers, faced with a rapidly expanding population and rising numbers of HIV/AIDS infections," to integrate family planning into HIV counseling and testing programs in the country. "When counseling women on reproductive health or child immunization, family planning clinics can also discuss HIV testing and prevention, particularly condom use, as well as introducing pregnant women to mother-to-child HIV transmission prevention services," the newspaper notes.
NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet, Sinemet CR or Stalevo, in patients with advanced Parkinson's disease.
› Verified 5 days ago